CatNameSizePrice
MBS6296214-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLight 650)0.1 mLAsk
MBS6296211-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLight 405)0.1 mLAsk
MBS6296207-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (APC)0.2 mLAsk
MBS6296206-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (AP)0.2 mLAsk
MBS6296187-01ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (FITC)0.2 mLAsk
MBS6296397-01ERBB2, Phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Az0.2 mLAsk
MBS6296396-01ERBB2, Phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (FI0.2 mLAsk
MBS6296393-01ERBB2, Phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (AP0.2 mLAsk
MBS6296359-01ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (P0.2 mLAsk
MBS6296357-01ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M0.1 mLAsk
MBS6296356-01ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M0.1 mLAsk
MBS6296353-01ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296352-01ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F0.2 mLAsk
MBS6296328-01ERBB2, Phosphorylated (Y1139) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296318-01ERBB2, Phosphorylated (Y1127) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (B0.2 mLAsk
MBS629231-01ErbB2, phosphorylated (Tyr877) (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL)0.05 mgAsk
MBS628430-01Nm23, NT (Nonmetastatic Protein 23, AWD, Granzyme A Activated DNase, GZMA Activated DNase, GAAD, Metastasis Inhibition Factor nm23, NB, NBS, NM23-H1, NM23-H1B, Non-metastatic Cells 1 Protein, NME1, Nucleoside Diphosphate Kinase A, NDP Kinase A, NDK A, NDK0.2 mLAsk
MBS6244674-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (PE)0.1 mLAsk
MBS6246273-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (MaxLight 550)0.1 mLAsk
MBS6245207-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (MaxLight 405)0.1 mLAsk
MBS6130180-01BAMBI (BMP and Activin Membrane-bound Inhibitor Homolog, Non-metastatic Gene A Protein, NMA, Putative Transmembrane Protein NMA) (AP)0.1 mLAsk
R8235086-PM-10Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Breast2x 10 µgAsk
BR1008bBreast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result. 100 cases/100 cores, replacing BR1008a-BR1008beachAsk
KD603Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores1 EachAsk
BRM961aBreast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores-BRM961aeachAsk
LC817bLung cancer with matched lymph node metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC817a1 EachAsk
MBS6131158-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (AP)0.1 mLAsk
MBS6150203-01TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (F0.1 mLAsk
MBS6153257-01KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (HRP)0.1 mLAsk
MBS6156695-01BAMBI (BMP and Activin Membrane-bound Inhibitor Homolog, Non-metastatic Gene A Protein, NMA, Putative Transmembrane Protein NMA) (PE)0.1 mLAsk
MBS6170352-01NME4 (Non-Metastatic Cells 4, Protein Expressed in, NDPK-D, NM23H4, nm23-H4) (APC)0.1 mLAsk
MBS6144900-01TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (B0.1 mLAsk
MBS6154795-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (HRP)0.1 mLAsk
MBS6147067-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (FITC)0.1 mLAsk
MBS6135089-01NME1 (Nucleoside Diphosphate Kinase A, NDP Kinase A, NDK A, Tumor Metastatic Process-Associated Protein, Metastasis Inhibition Factor nm23, nm23-H1, Granzyme A-Activated DNase, GAAD, NDPKA, NM23) (Azide Free) APC0.1 mLAsk
MBS6147954-01KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (FITC)0.1 mLAsk
MBS6203833-01TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M0.1 mLAsk
MBS6239642-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 750)0.1 mLAsk
MBS6239641-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 750)0.1 mLAsk
MBS6239636-01NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in, AWD, GAAD, NB, NBS, NDPK-A, NDPKA, NM23, NM23-H1) (MaxLight 750)0.1 mLAsk
MBS6232721-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (MaxLight 750)0.1 mLAsk
MBS6222950-01LASP1 (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50) (MaxLight 650)0.1 mLAsk
MBS6222046-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (MaxLight 650)0.1 mLAsk
MBS6209802-01NME1 (Nucleoside Diphosphate Kinase A, NDP Kinase A, NDK A, Tumor Metastatic Process-Associated Protein, Metastasis Inhibition Factor nm23, nm23-H1, Granzyme A-Activated DNase, GAAD, NDPKA, NM23) (Azide Free) (MaxLight 550)0.1 mLAsk
MBS6207617-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 490)0.1 mLAsk
MBS6207616-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 490)0.1 mLAsk
MBS6207611-01NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in, AWD, GAAD, NB, NBS, NDPK-A, NDPKA, NM23, NM23-H1) (MaxLight 490)0.1 mLAsk
MBS6201600-01LASP1 (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50) (MaxLight 490)0.1 mLAsk
MBS6214228-01STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) (MaxLight 550)0.1 mLAsk
MBS6228968-01NME3 (Non-Metastatic Cells 3, Protein Expressed in, DR-nm23, KIAA0516, NDPK-C, NDPKC, NM23-H3, c371H6.2) (MaxLight 650)0.1 mLAsk
MBS6228965-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 650)0.1 mLAsk
MBS6228962-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 650)0.1 mLAsk
MBS6224903-01STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) (MaxLight 650)0.1 mLAsk
MBS6224472-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 650)0.1 mLAsk
MBS6218290-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 550)0.1 mLAsk
MBS6200696-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (MaxLight 490)0.1 mLAsk
MBS6174910-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (FITC)0.1 mLAsk
MBS6174762-01NME4 (Non-Metastatic Cells 4, Protein Expressed in, NDPK-D, NM23H4, nm23-H4) (Biotin)0.1 mLAsk
MBS6176720-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (FITC)0.1 mLAsk
MBS6190925-01LASP1 (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50) (MaxLight 405)0.1 mLAsk
MBS6190908-01KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (MaxLight 405)0.1 mLAsk
MBS6196942-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 405)0.1 mLAsk
MBS6196940-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 405)0.1 mLAsk
MBS6196938-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 405)0.1 mLAsk
MBS6196937-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (MaxLight 405)0.1 mLAsk
MBS6181183-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (HRP)0.1 mLAsk
MBS6185593-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (PE)0.1 mLAsk
MBS6166090-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (APC)0.1 mLAsk
MBS6166089-01NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in, AWD, GAAD, NB, NBS, NDPK-A, NDPKA, NM23, NM23-H1) (APC)0.1 mLAsk
MBS6161679-01NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in, AWD, GAAD, NB, NBS, NDPK-A, NDPKA, NM23, NM23-H1) (AP)0.1 mLAsk
MBS6166812-01NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf) (APC)0.1 mLAsk
MBS6012993-01LASP1, ID (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50)0.05 mgAsk
abx068329-01Mouse Non Metastatic Cells 3, Protein NM23A Expressed In (NME3) Protein10 µgAsk
MBS6012603-01ERBB2, phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340)0.2 mLAsk
MBS6006896-01ERBB2, phosphorylated (Y1127) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340)0.2 mLAsk
abx068330-01Mouse Non Metastatic Cells 4, Protein NM23A Expressed In (NME4) Protein10 µgAsk
MBS6003206-01ERBB2, phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340)0.2 mLAsk
MBS6002447-01STEA2, ID (STEAP2, PCANAP1, STAMP1, Metalloreductase STEAP2, Prostate cancer-associated protein 1, Protein up-regulated in metastatic prostate cancer, Six-transmembrane epithelial antigen of prostate 2, SixTransMembrane protein of prostate 1)0.2 mLAsk
abx068333-01Rat Non Metastatic Cells 6, Protein Expressed In (NME6) Protein10 µgAsk
LV1221Liver primary cancer and metastatic cancer tissue array (most are stage IV), containing NAT sample, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, carcinoid, adenosquamous carcinoma, mixed carcinoma, metastatic carcinoma samples, 100 cases/122 cores-LV1221eachAsk
T8235142-PMMatched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM) : Kidney2x 5 SlidesAsk
T8235086-PMMatched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM) : Breast2x 5 SlidesAsk
R8235248-PM-10Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Stomach2x 10 µgAsk
abx068334-01Mouse Non Metastatic Cells 6, Protein Expressed In (NME6) Protein10 µgAsk